Alex Shvartsburg serves as the Chief Financial Officer (CFO) at LivaNova PLC, a global medical technology and innovation company focused on developing and delivering solutions for cardiovascular and neuromodulation diseases. In his role as CFO, Shvartsburg is responsible for overseeing the financial strategy and operations of the company, ensuring its fiscal health and sustainability. He plays a crucial role in driving LivaNova's growth and profitability, managing investor relations, and guiding the company through strategic financial decisions. Prior to joining LivaNova in 2019, Shvartsburg held several high-profile positions in the medical device and technology sectors. He was the CFO at Wright Medical Group N.V., where he played a pivotal role in the company's financial restructuring and eventual acquisition by Stryker Corporation. Before that, he served as CFO at Baxano Surgical, Inc., and held various senior financial roles at companies such as Abbott Laboratories and Boston Scientific Corporation. Shvartsburg's extensive experience in finance and strategic planning within the medical industry has been instrumental in his success at LivaNova. Shvartsburg's achievements extend beyond his corporate roles. He holds an MBA from the University of Chicago Booth School of Business and a Bachelor of Science in Finance from the University of Illinois at Urbana-Champaign. His strategic vision and leadership have been recognized in the industry, contributing to LivaNova's position as a leader in medical technology. Under his guidance, LivaNova continues to innovate and expand its reach, improving patient outcomes and advancing healthcare solutions worldwide.